The “Sweet Spot” of Targeting Tumor Metabolism in Ovarian Cancers

SIMPLE SUMMARY: Ovarian cancer is the most lethal gynecologic malignancy. While most patients will initially respond to treatment, the majority will recur and develop chemoresistance. Therefore, we require a better understanding of how cancer cells evade chemotherapy, including the reprogramming of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tondo-Steele, Katelyn, McLean, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562887/
https://www.ncbi.nlm.nih.gov/pubmed/36230617
http://dx.doi.org/10.3390/cancers14194696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562887/
https://www.ncbi.nlm.nih.gov/pubmed/36230617
http://dx.doi.org/10.3390/cancers14194696

Ejemplares similares